FIG 8.
ADE and ΔPRNT50 by plasma from patients with different severities of RSV-mediated disease symptoms. RSV neutralization assays using plasma samples from patients with moderate or severe RSV-mediated disease and healthy control patients (uninfected). Maximum ADE (A) and plasma titer at which ADE was maximal (B) were compared to disease severity. (C) ΔPRNT50 was compared to disease severity. Statistical analyses employed one-way analysis of variance for comparison between the three disease groups (**, P < 0.01).